Merck & Co. has added 120,000 square feet of manufacturing capacity at its Rockingham County site to support continued scale-up of its Gardasil HPV vaccines. Human papillomavirus (HPV) vaccines Gardasil and Gardasil 9 pulled in $1.5 billion for Merck last year, and while the firm has predicted sales to double by 2030 as demand continues, this is reliant on having the manufacturing capacity in place. With this in mind, it is good news today for Merck as it announces the…
ThermoGenesis has leased a facility in Sacramento, California to house its newly launched CDMO cell therapy business TG Biosynthesis. ThermoGenesis (formerly known as Cesca Therapeutics), which provides cell processing tools and services to the cell and gene therapy sector, is bolstering its offering by creating a cell therapy production division.  The firm will deliver contract development manufacturing organization (CDMO) services under the name TG Biosynthesis. To create this, ThermoGenesis entered into a license and technology agreement with Boyalife Genomics, a…